Martens Penny J, Ly Mai, Adams Damian H, Penzkover Kathryn R, Strudwick Xanthe, Cowin Allison J, Poole-Warren Laura A
Graduate School of Biomedical Engineering, UNSW Australia, Sydney, Australia
Graduate School of Biomedical Engineering, UNSW Australia, Sydney, Australia Cooperative Research Centre for Polymers, Notting Hill, Australia.
J Biomater Appl. 2015 Sep;30(3):257-68. doi: 10.1177/0885328215579422. Epub 2015 Apr 2.
Gene silencing using small interfering RNA has been proposed as a therapy for cancer, viral infections and other diseases. This study aimed to investigate whether layer-by-layer polymer surface modification could deliver small interfering RNA to decrease fibrotic processes associated with medical device implantation. Anti-green fluorescent protein labelled small interfering RNA was applied to tissue culture plates and polyurethane using a layer-by-layer technique with small interfering RNA and poly-L-lysine. In vitro studies showed that the level of down-regulation of green fluorescent protein was directly related to the number of coatings applied. This layer-by-layer coating technique was then used to generate Rhodamine-Flii small interfering RNA-coated implants for in vivo studies of small interfering RNA delivery via subcutaneous implantation in mice. After two days, Rh-positive cells were observed on the implants' surface indicating cellular uptake of the Rhodamine-Flii small interfering RNA. Decreased Flii gene expression was observed in tissue surrounding the Rhodamine-Flii small interfering RNA coated implants for up to seven days post implantation, returning to baseline by day 21. Genes downstream from Flii, including TGF-β1 and TGF-β3, showed significantly altered expression confirming a functional effect of the Rhodamine-Flii small interfering RNA on gene expression. This research demonstrates proof-of-principle that small interfering RNA can be delivered via layer-by-layer coatings on biomaterials and thereby can alter the fibrotic process.
利用小干扰RNA进行基因沉默已被提议作为治疗癌症、病毒感染和其他疾病的一种疗法。本研究旨在调查逐层聚合物表面修饰是否能够递送小干扰RNA,以减少与医疗器械植入相关的纤维化过程。使用小干扰RNA和聚-L-赖氨酸的逐层技术,将抗绿色荧光蛋白标记的小干扰RNA应用于组织培养板和聚氨酯。体外研究表明,绿色荧光蛋白的下调水平与所施加的涂层数量直接相关。然后,这种逐层涂层技术被用于制备罗丹明-Flii小干扰RNA包被的植入物,用于通过小鼠皮下植入对小干扰RNA递送进行体内研究。两天后,在植入物表面观察到罗丹明阳性细胞,表明细胞摄取了罗丹明-Flii小干扰RNA。在植入罗丹明-Flii小干扰RNA包被的植入物周围的组织中,观察到Flii基因表达在植入后长达七天内降低,并在第21天恢复到基线水平。Flii下游的基因,包括TGF-β1和TGF-β3,显示出表达的显著改变,证实了罗丹明-Flii小干扰RNA对基因表达的功能作用。这项研究证明了原理,即小干扰RNA可以通过生物材料上的逐层涂层递送,从而可以改变纤维化过程。